Anbio Biotechnology Class A Ordinary Shares Statistics
Share Statistics
Anbio Biotechnology Class A Ordinary Shares has 43.89M
shares outstanding. The number of shares has increased by null%
in one year.
| Shares Outstanding | 43.89M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 233 |
| FTD / Avg. Volume | 0.24% |
Short Selling Information
The latest short interest is 20.01K, so 0.05% of the outstanding
shares have been sold short.
| Short Interest | 20.01K |
| Short % of Shares Out | 0.05% |
| Short % of Float | 0.05% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
| PE Ratio | 0 |
| Forward PE | n/a |
| PS Ratio | 0 |
| Forward PS | n/a |
| PB Ratio | 0 |
| P/FCF Ratio | 0 |
| PEG Ratio | 0 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Anbio Biotechnology Class A Ordinary Shares.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.71,
with a Debt / Equity ratio of 0.
| Current Ratio | 10.71 |
| Quick Ratio | 10.71 |
| Debt / Equity | 0 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $303,153.56 |
| Profits Per Employee | $87,883.04 |
| Employee Count | 27 |
| Asset Turnover | 0.43 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by null% in the
last 52 weeks. The beta is 0, so Anbio Biotechnology Class A Ordinary Shares's
price volatility has been lower than the market average.
| Beta | 0 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 6.95 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 64.03 |
| Average Volume (20 Days) | 95,133 |
Income Statement
In the last 12 months, Anbio Biotechnology Class A Ordinary Shares had revenue of 8.19M
and earned 2.37M
in profits. Earnings per share was 0.
| Revenue | 8.19M |
| Gross Profit | 5.89M |
| Operating Income | 2M |
| Net Income | 2.37M |
| EBITDA | 2.57M |
| EBIT | 2.37M |
| Earnings Per Share (EPS) | 0 |
Full Income StatementBalance Sheet
The company has 11.76M in cash and 0 in
debt, giving a net cash position of 11.76M.
| Cash & Cash Equivalents | 11.76M |
| Total Debt | n/a |
| Net Cash | n/a |
| Retained Earnings | 17.17M |
| Total Assets | n/a |
| Working Capital | n/a |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was 2.08M
and capital expenditures 0, giving a free cash flow of 2.08M.
| Operating Cash Flow | 2.08M |
| Capital Expenditures | n/a |
| Free Cash Flow | 2.08M |
| FCF Per Share | 0 |
Full Cash Flow StatementMargins
Gross margin is 71.9%, with operating and profit margins of 24.38% and 28.99%.
| Gross Margin | 71.9% |
| Operating Margin | 24.38% |
| Pretax Margin | 28.99% |
| Profit Margin | 28.99% |
| EBITDA Margin | 31.36% |
| EBIT Margin | 24.38% |
| FCF Margin | 25.42% |
